MD Biosciences providing up-to-date news coverage compiling posts from science journals including Cancer Research, Sci News, Nature Genetics, British Journal of Pharmacology and Science reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye!
TOP SCIENCE NEWS
Image credit: Charles J. Sharp
ieAstrocytes Identified As a Key Contributor to Neuroinflammation Diseases
-
Researchers at Sanford Burnham Medical Discovery Institute discuss an active cell type in vivo present in neuroinflammatory conditions. Reported by Gen.
Neonatal Inflammatory Markers Predictive of Childhood Leukemia
- Researchers from Statens Serum Institut in Denmark measured blood concentrations of eight inflammatory markers and they found statistically significant differences in patients that were later diagnosed with leukemia compared to controls. Published in Cancer Research, and reported by Gen.
Newly Emerging Cancer Treatment
- Engineered killer cells show potential for cancer treatment in preliminary clinical trials started by scientists at the University of Texas MD Anderson Cancer Center.
Using Bee Venom As a Treatment for Atopic Dermatitis
- A team of scientists from the Catholic University of Daegu found that Melittin, a component of bee venom, suppresses inflammatory responses happening in various immune mechanisms. Published in British Journal of Pharmacology and reported by Sci News.
First Koala Genome Sequencing Completed
- Researchers from 29+ science institutions successfully created a genome sequence, helping to illuminate new conservation strategies and help in treating disease to prevent further survival threats for Koalas. Published in Nature Genetics, posted by Sci News.
Hope you learned something new! Check back next Tuesday for informed, up-to-date science news, or contact us with specific inquiries.
